PCN245 GRADE 3/4 ADVERSE EVENT (AE) COSTS OF NIVOLUMAB...

Value in Health 2019 / 11 Vol. 22

PCN245 GRADE 3/4 ADVERSE EVENT (AE) COSTS OF NIVOLUMAB VERSUS DABRAFENIB + TRAMETINIB AS ADJUVANT TREATMENT IN PATIENTS WITH STAGE III BRAF-MUTATED CUTANEOUS MELANOMA IN PORTUGAL

Alves, D., Amadi, A., Moshyk, A., Betts, K., Du, E.X.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
22
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.09.440
Date:
November, 2019
File:
PDF, 382 KB
2019
Conversion to is in progress
Conversion to is failed